Cases 41 - 50 of 5,523
J. A. H. et al v. Johnson & Johnson et al
as 2:2022cv00472
Plaintiff:
J. A. H. and J. S., IV
Defendant:
Johnson & Johnson, Janssen Pharmaceuticals, Inc., Noramco and others
Cause Of Action: 28 U.S.C. § 1332 Diversity-Personal Injury
K.A.D. et al v. Johnson & Johnson et al
as 2:2022cv00476
Plaintiff:
K. A. D. and B. D. G.
Defendant:
Johnson & Johnson, Janssen Pharmaceuticals, Inc., Noramco and others
Cause Of Action: 28 U.S.C. § 1332 Diversity-Personal Injury
Plaintiff v. Defendant
as 2:2022cv04022
Plaintiff:
Plaintiff v. Defendant
Defendant:
Plaintiff v. Defendant
Cause Of Action: 42 U.S.C. § 2000 e Job Discrimination (Employment)
Avent v. Paratek Pharmaceuticals, Inc.
as 1:2022cv02814
Plaintiff:
Tracey Avent and Tina Alianiello
Defendant:
Paratek Pharmaceuticals, Inc.
Cause Of Action: 29 U.S.C. § 201 Fair Labor Standards Act
Mann et al v. Johnson & Johnson et al
as 1:2022cv03227
Plaintiff:
Ellen B Mann, Antoine Mann and Rae Mann
Defendant:
Johnson & Johnson and Janssen Pharmaceuticals, Inc.
Cause Of Action: 28 U.S.C. § 1446 Notice of Removal
Otsuka Pharmaceutical Co., Ltd. et al v. Mylan Laboratories Limited et al
as 1:2022cv00114
Plaintiff:
Otsuka Pharmaceutical Co., Ltd. and H. Lundbeck A/S
Defendant:
Mylan Laboratories Limited, Viatris Inc. and Mylan Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Bausch Health Ireland Limited et al v. Mylan Pharmaceuticals, Inc.
as 1:2022cv00085
Plaintiff:
Bausch Health Ireland Limited and Salix Pharmaceuticals, Inc.
Defendant:
Mylan Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Gray v. Aurobindo Pharma Ltd. et al
as 1:2022cv02353
Plaintiff:
Louise Gray
Defendant:
Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc., Sciegen Pharmaceuticals, Inc. and others
Cause Of Action: 28 U.S.C. § 1446 Notice of Removal
Zaifert v. Avanir Pharmaceuticals, Inc.
as 2:2022cv03547
Plaintiff:
Matthew Zaifert
Defendant:
Avanir Pharmaceuticals, Inc.
Cause Of Action: 28 U.S.C. § 1332 Diversity-Other Contract
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc.
as 1:2022cv00061
Plaintiff:
Regeneron Pharmaceuticals, Inc.
Defendant:
Mylan Pharmaceuticals Inc.
Cause Of Action: 28 U.S.C. § 1338 Patent Infringement
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
